This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice.
The Journal of pharmacology and experimental therapeutics · 2020
Latest funding
- $12,450,001
SPOR Network in Diabetes and its Related Complications
CIHR · 2015 · Principal investigator
1 publications.
Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice.
Jolivalt CG, Frizzi KE, Han MM, Mota AJ, Guernsey LS, Kotra LP, Fernyhough P, Calcutt NA
SPOR Network in Diabetes and its Related Complications
Principal investigators: Lewis, Gary F; Brown, Adalsteinn D; Maberley, David; Rochon, Paula A; Sullivan, Frank; Bélanger, Mathieu; Brent, Michael H; Cafazzo, Joseph A; Carpentier, André C; Després, Jean-Pierre; Farkouh, Michael E; Fernyhough, Paul; Légaré, France; McGavock, Jonathan M; Perkins, Bruce A
Keywords: Clinical Trials; Diabetes; Diabetes Complications; Knowledge Translation; National Network
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.